| Literature DB >> 12217356 |
Veerle Vanheusden1, Hélène Munier-Lehmann, Sylvie Pochet, Piet Herdewijn, Serge Van Calenbergh.
Abstract
A number of 2'- and 3'-modified thymidine 5'-O-monophosphate analogues were synthesized as potential leads for new anti-mycobacterial drugs. Evaluation of their affinity for Mycobacterium tuberculosis thymidine monophosphate kinase showed that a 2'-halogeno substituent and a 3'-azido function are the most favorable leads for further development of potent inhibitors of this enzyme.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12217356 DOI: 10.1016/s0960-894x(02)00551-6
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823